Current stage-Stage I Posts on Medivizor
Navigation Menu

Current stage-Stage I Posts on Medivizor

Are intense follow-up programs beneficial for patients with colorectal cancer?

Posted by on Jan 10, 2020 in Colorectal cancer | 0 comments

In a nutshell This study reviewed the effect of follow-up programs on the survival of patients with colorectal cancer. Researchers suggested that intense follow-up programs do not improve the survival of these patients. Some background Colorectal cancer is a commonly diagnosed cancer in the US. Two in three patients will present with the possibly...

Read More

Complete mesocolic excision reduces the risk of recurrence in patients with colon cancer

Posted by on Dec 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of complete mesocolic excision (CME) in patients with right-side colon cancer. Researchers suggested that CME reduces the risk of recurrences (when cancer comes back) in these patients. Some background Colorectal cancer is one of the most common cancers worldwide. The standard treatment is surgery and...

Read More

A comparison between local and radical surgery in early rectal cancer

Posted by on Jun 20, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of local vs radical surgery in patients with rectal cancer. Researchers suggested that local surgery is associated with better outcomes in certain patients with early cancers. Some background Colorectal cancer is the third most common cancer in the US. The standard treatment options for these...

Read More

Chemotherapy before breast conserving surgery in breast cancer – is there an increased risk of complications?

Posted by on May 21, 2019 in Breast cancer | 0 comments

In a nutshell This study investigated the effect of neoadjuvant chemotherapy (NAC; chemotherapy before surgery) in patients undergoing oncoplastic breast-conserving surgery (OBCS).  They found that NAC did not affect the rate of complications in OBCS.  Some background Breast cancer (BC) can be treated using a number of strategies....

Read More

Denosumab treatment in HR+ breast cancer

Posted by on Apr 30, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if adding the medication denosumab (Prolia, Xgeva) to cancer treatment for women with breast cancer reduces the risk of bone fractures. The study found that the patients treated with denosumab survived better, but there was no significant difference in the number of bone fractures. Some background Breast...

Read More

Enhanced recovery pathways improve outcomes for patients with rectal cancer

Posted by on Apr 8, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of patients with rectal cancer who received enhanced recovery pathway (ERP) in combination with surgery. Researchers suggested that ERP was associated with longer overall survival. Some background The standard treatment for rectal cancer is surgery, chemotherapy and radiation therapy. However, rectal...

Read More

Searching for patients with early stage breast cancer to trial a new radiation treatment plan

Posted by on Mar 27, 2019 in Breast cancer | 0 comments

In a nutshell The trial aims to investigate a new way of delivering radiation therapy in women with early-stage breast cancer. This will involve low doses of radiation therapy being aimed at the part of the breast where the tumor is or was. The main outcomes that will be measured are side effects and recurrence rate. This trial is recruiting in Missouri,...

Read More

Looking for patients with early rectal cancer to test less invasive surgery with chemotherapy

Posted by on Mar 26, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness of chemotherapy followed by a less invasive surgery for early rectal cancer. The main outcome will be the number of patients keeping their rectum. This trial is being conducted in Canada and the United States. The details Rectal cancer is one of the most common cancers in the US. The standard...

Read More

SBRT vs. radiotherapy in patients with inoperable non-small cell lung cancer

Posted by on Mar 5, 2019 in Lung cancer | 0 comments

In a nutshell This study determined whether stereotactic body radiation therapy (SBRT) was more effective than standard radiotherapy in patients with inoperable non-small cell lung cancer. The study found that SBRT led to better survival outcomes for these patients, with minimal side effects. Some background Tumor removal by surgery is the standard of...

Read More